Table 2.
Classification of patients by risk group and presence of NAAD
Risk Group | NAAD | Total | P | |
---|---|---|---|---|
No | Yes | |||
IR | 9 (56.2%) | 7 (43.7%) | 16 (41.0%) | 0.407 |
HR | 15 (65.2%) | 8 (34.8%) | 23 (59.0%) | 0.740 |
Total | 24 (61.5%) | 15 (38.5) | 39 (100.0%) |
NAAD: neoadjuvant androgen deprivation; IR: intermediate risk for biochemical failure; HR: high risk for biochemical failure.